1315 Capital News and M&A Summary, 8 Deals Between 2014 and 2019

In the last 3 years, 1315 Capital has acquired 3 companies.

1315 Capital’s most common sectors for investment are life science (38%) and medical products (38%). The Firm’s most common investment types include venture (50%) and divestiture (25%). In total, 1315 Capital has invested in 6 US states.

Join Mergr to view 1315 Capital’s full profile and discover more small private equity firms just like it.

1315 Capital


1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $30 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.

M&A Summary

Buy vs Sell

Top M&A Advisors

Join Mergr to view the latest updates and news from 1315 Capital.

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.7K Private Equity Firms
  • 132K M&A Transactions
  • 141K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.0K M&A Advisors
    (Investment Banks and Law Firms)
  • 37K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.